SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-006741
Filing Date
2023-02-01
Accepted
2023-02-01 17:13:15
Documents
11
Period of Report
2023-02-01

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea172522-6k_mesoblast.htm 6-K 19558
2 APPENDIX 4C OF MESOBLAST LTD, DATED JANUARY 31, 2023 ea172522ex99-1_mesoblast.htm EX-99.1 139199
3 PRESS RELEASE OF MESOBLAST LTD, DATED JANUARY 31, 2023 ea172522ex99-2_mesoblast.htm EX-99.2 34296
4 GRAPHIC ex99-1_001.jpg GRAPHIC 11629
5 GRAPHIC ex99-1_002.jpg GRAPHIC 9082
6 GRAPHIC ex99-1_003.jpg GRAPHIC 5217
7 GRAPHIC ex99-1_004.jpg GRAPHIC 34596
8 GRAPHIC ex99-2_001.jpg GRAPHIC 3696
9 GRAPHIC ex99-2_002.jpg GRAPHIC 2779
10 GRAPHIC ex99-2_003.jpg GRAPHIC 3200
11 GRAPHIC ex99-2_004.jpg GRAPHIC 13344
  Complete submission text file 0001213900-23-006741.txt   310265
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 23577814
SIC: 2836 Biological Products, (No Diagnostic Substances)